Physician profile
Evens Rodney
NPI 1093716565
$1,732.76
in general payments reported to CMS, 2019-2025
23 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $60.03 · 2021: $237 · 2022: $290 · 2023: $409 · 2024: $358 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $999.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $334.29 | 2022-2025 | Onpattro |
| Baxter Healthcare | $171.97 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor |
| Amgen INC. | $167.54 | 2019-2025 | Repatha |
| Shockwave Medical, INC | $96.61 | 2022 | |
| Silk Road Medical, INC. | $94.74 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $79.69 | 2023-2024 | Farxiga, Wainua |
| Esperion Therapeutics, INC. | $78.43 | 2021-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $77.11 | 2021-2024 | Verquvo |
| Novartis Pharmaceuticals Corporation | $76.98 | 2019-2022 | |
| Pfizer INC. | $73.66 | 2019-2024 | |
| Itamar Medical INC | $70.03 | 2025 | Watchpatone |
| Janssen Pharmaceuticals, INC | $60.99 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $57.91 | 2023 | Optimizer |
| Lexicon Pharmaceuticals, INC. | $57.62 | 2023-2024 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.35 | 2023-2024 | Jardiance |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $37.58 | 2024 | Corevalve Evolut R |
| Irhythm Technologies, INC. | $30.99 | 2024 | Zio Xt Patch, Zio Monitor |
| Boston Scientific Corporation | $24.29 | 2025 | Bodyguardian |
| Abbott Laboratories | $24.15 | 2025 | Cardiomems |
| Cardiovascular Systems INC. | $22.21 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $21.24 | 2024 | Arcalyst |
| Scpharmaceuticals INC. | $19.88 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $16.50 | 2024 | Camzyos |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evens Rodney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.